Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab Safety in RA
NCT00036387Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of infliximab in rheumatoid arthritis (RA), sponsored by Janssen Pharmaceutical. Status: completed.
02
Drugs
infliximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00036387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00036387.